These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 36967456)
21. [Education Program of Kampo-medicine for Undergraduates in Preparation for Clinical Setting]. Homma M Yakugaku Zasshi; 2016; 136(3):417-22. PubMed ID: 26935080 [TBL] [Abstract][Full Text] [Related]
22. Safety and Effectiveness of Ninjin'yoeito: A Utilization Study in Elderly Patients. Suzuki S; Aihara F; Shibahara M; Sakai K Front Nutr; 2019; 6():14. PubMed ID: 30873411 [TBL] [Abstract][Full Text] [Related]
23. Onion component, isoalliin, stimulates feeding and activates the arcuate nucleus neuropeptide Y, ghrelin- and Ninjin'yoeito-responsive neurons. Wang L; Han W; Iwasaki Y; Yermek R; Sharp GWG; Seino Y; Yada T Neuropeptides; 2021 Oct; 89():102180. PubMed ID: 34293597 [TBL] [Abstract][Full Text] [Related]
24. Ninjin'yoeito Targets Distinct Ca Goswami C; Dezaki K; Wang L; Inui A; Seino Y; Yada T Front Nutr; 2020; 7():104. PubMed ID: 32766273 [TBL] [Abstract][Full Text] [Related]
25. Traditional Chinese medicine and Kampo: a review from the distant past for the future. Yu F; Takahashi T; Moriya J; Kawaura K; Yamakawa J; Kusaka K; Itoh T; Morimoto S; Yamaguchi N; Kanda T J Int Med Res; 2006; 34(3):231-9. PubMed ID: 16866016 [TBL] [Abstract][Full Text] [Related]
26. Improvement in Frailty in a Patient With Severe Chronic Obstructive Pulmonary Disease After Ninjin'yoeito Therapy: A Case Report. Kuniaki H; Akihiko T; Tetsuya H; Hatsuko M; Tomoko K; Shin O; Sojiro K; Mayumi Y; Fumihiro Y; Shintaro S; Tsukasa O; Hironori S Front Nutr; 2018; 5():71. PubMed ID: 30234120 [TBL] [Abstract][Full Text] [Related]
27. Case Report: Efficacy of Ninjin'yoeito Treatment for Idiopathic Pulmonary Fibrosis. Kushima H; Ishii H; Fujita M Front Nutr; 2021; 8():548076. PubMed ID: 33996870 [TBL] [Abstract][Full Text] [Related]
28. Perspectives on the Use of Ninjin'yoeito in Modern Medicine: A Review of Randomized Controlled Trials. Takayama S; Arita R; Ohsawa M; Kikuchi A; Yasui H; Makino T; Motoo Y; Ishii T Evid Based Complement Alternat Med; 2019; 2019():9590260. PubMed ID: 31565066 [TBL] [Abstract][Full Text] [Related]
29. Status of urological Kampo medicine: a narrative review and future vision. Minagawa T; Ishizuka O Int J Urol; 2015 Mar; 22(3):254-63. PubMed ID: 25597936 [TBL] [Abstract][Full Text] [Related]
30. Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use. Ikegami F; Sumino M; Fujii Y; Akiba T; Satoh T Hum Exp Toxicol; 2006 Aug; 25(8):481-94. PubMed ID: 16937920 [TBL] [Abstract][Full Text] [Related]
31. Prophylactic efficacy of ninjin'yoeito for oxaliplatin-induced cumulative peripheral neuropathy in patients with colorectal cancer receiving postoperative adjuvant chemotherapy: a randomized, open-label, phase 2 trial (HOPE-2). Motoo Y; Tomita Y; Fujita H Int J Clin Oncol; 2020 Jun; 25(6):1123-1129. PubMed ID: 32232692 [TBL] [Abstract][Full Text] [Related]
32. Kampo medicines as alternatives for treatment of migraine: six case studies. Ishida K; Sato H Complement Ther Clin Pract; 2006 Nov; 12(4):276-80. PubMed ID: 17030300 [TBL] [Abstract][Full Text] [Related]
33. Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study. Ito T; Konishi A; Tsubokura Y; Azuma Y; Hotta M; Yoshimura H; Nakanishi T; Fujita S; Nakaya A; Satake A; Ishii K; Nomura S Front Nutr; 2018; 5():72. PubMed ID: 30186837 [TBL] [Abstract][Full Text] [Related]
34. Role of Kampo Medicine in Modern Cancer Therapy: Towards Completion of Standard Treatment. Motoo Y J Nippon Med Sch; 2022 May; 89(2):139-144. PubMed ID: 34840211 [TBL] [Abstract][Full Text] [Related]
35. Case Report: Ninjin'yoeito May Improve Quality of Life After Hospitalization for Acute Illness in Patients With Frailty. Kashima M Front Nutr; 2021; 8():547512. PubMed ID: 33937301 [No Abstract] [Full Text] [Related]
36. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial. Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479 [TBL] [Abstract][Full Text] [Related]
37. Perceptions and attitudes of Japanese gynecologic cancer patients to Kampo (Japanese herbal) medicines. Takeda T; Yamaguchi T; Yaegashi N Int J Clin Oncol; 2012 Apr; 17(2):143-9. PubMed ID: 21706124 [TBL] [Abstract][Full Text] [Related]
38. Good Rehabilitation Outcomes and Improved Nutritional Status After Treatment With the Japanese Herbal Medicine Ninjin'yoeito in an Elderly Patient With Hip Fracture and Sarcopenia: A Case Report. Morinaga A; Nakamura H; Hattanmaru K; Rokot NT; Kimura Y; Ito T Front Nutr; 2020; 7():85. PubMed ID: 32714940 [TBL] [Abstract][Full Text] [Related]
39. [Changes in peripheral lymphocytes count in unconscious patients treated at home with Japanese herbal medicines (Hozai)]. Kitahara M; Ishikawa S; Hara K; Kanno S; Ogata F; Naruo K; Yaguchi A Gan To Kagaku Ryoho; 2002 Dec; 29 Suppl 3():526-9. PubMed ID: 12536844 [TBL] [Abstract][Full Text] [Related]
40. Abdominal fullness and discomfort induced by an extract of the Japanese herbal medicine Tsumura Ninjin'yoeito: The cases of two patients with Alzheimer's disease and anorexia. Sato S; Tamura M; Ide M; Matsuzaki A; Shiratori Y; Hisanaga A Psychiatry Clin Neurosci; 2022 Aug; 76(8):406-407. PubMed ID: 35638555 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]